PM534
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for PM534, covering 2025-08-22 to 2025-08-22. Get the full timeline:
Most recent: Clinical Trial Update: PM534 Administered Intravenously to Patients With Advanced Solid Tumors [Phase 1]